Your browser doesn't support javascript.
loading
Challenges and opportunities of CAR T-cell therapies for CLL.
Zhao, Ziran; Grégoire, Céline; Oliveira, Beatriz; Chung, Kunho; Melenhorst, Jan Joseph.
Afiliação
  • Zhao Z; Cell Therapy & Immuno-Engineering Program, Center for ImmunoTherapy and Precision Immuno-Oncology, Lerner College of Medicine, Cleveland Clinic, Cleveland, OH.
  • Grégoire C; Cell Therapy & Immuno-Engineering Program, Center for ImmunoTherapy and Precision Immuno-Oncology, Lerner College of Medicine, Cleveland Clinic, Cleveland, OH.
  • Oliveira B; Cell Therapy & Immuno-Engineering Program, Center for ImmunoTherapy and Precision Immuno-Oncology, Lerner College of Medicine, Cleveland Clinic, Cleveland, OH.
  • Chung K; Cell Therapy & Immuno-Engineering Program, Center for ImmunoTherapy and Precision Immuno-Oncology, Lerner College of Medicine, Cleveland Clinic, Cleveland, OH.
  • Melenhorst JJ; Cell Therapy & Immuno-Engineering Program, Center for ImmunoTherapy and Precision Immuno-Oncology, Lerner College of Medicine, Cleveland Clinic, Cleveland, OH. Electronic address: melenhj@ccf.org.
Semin Hematol ; 60(1): 25-33, 2023 01.
Article em En | MEDLINE | ID: mdl-37080707

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Linfocítica Crônica de Células B Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Linfocítica Crônica de Células B Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article